Summit Rock Advisors, LP - Q2 2021 holdings

$252 Million is the total value of Summit Rock Advisors, LP's 4 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 71.4% .

 Value Shares↓ Weighting
IWN NewISHARES TRrus 2000 val etf$118,553,000715,164
+100.0%
46.98%
VTV BuyVANGUARD INDEX FDSvalue etf$79,368,000
+153.9%
577,391
+142.8%
31.45%
+196.2%
IUSV  ISHARES TRcore s&p us vlu$53,264,000
+4.4%
740,1950.0%21.11%
+21.8%
PHAT  PHATHOM PHARMACEUTICALS INC$1,154,000
-9.9%
34,1000.0%0.46%
+5.1%
FROG ExitJFROG LTD$0-10,079
-100.0%
-0.15%
IWM ExitISHARES TRrussell 2000 etf$0-152,585
-100.0%
-11.45%
VSS ExitVANGUARD INTL EQUITY INDEX Fftse smcap etf$0-338,612
-100.0%
-14.76%
VT ExitVANGUARD INTL EQUITY INDEX Ftt wrld st etf$0-1,369,410
-100.0%
-45.26%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR29Q3 202090.6%
ISHARES TR26Q4 202051.7%
ISHARES INC11Q1 202064.0%
ISHARES TR11Q4 202147.6%
ISHARES TR9Q2 201534.5%
PHATHOM PHARMACEUTICALS INC9Q2 20221.1%
ISHARES TR RUS 2000 VAL ETF7Q4 202247.0%
SELECT SECTOR SPDR TR ENERGY6Q3 202367.4%
VANGUARD INTL EQUITY INDEX F5Q3 202245.3%
VANGUARD INDEX FDS4Q4 202136.4%

View Summit Rock Advisors, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-01-26
13F-HR2023-10-24
13F-HR2023-07-21
13F-HR2023-05-09
13F-HR2023-01-12
13F-HR2022-11-02
13F-HR2022-08-01
13F-HR2022-05-06
13F-HR2022-02-14
13F-HR2021-10-26

View Summit Rock Advisors, LP's complete filings history.

Compare quarters

Export Summit Rock Advisors, LP's holdings